196 related articles for article (PubMed ID: 18279840)
1. Relative contribution of rat cytochrome P450 isoforms to the metabolism of caffeine: the pathway and concentration dependence.
Kot M; Daniel WA
Biochem Pharmacol; 2008 Apr; 75(7):1538-49. PubMed ID: 18279840
[TBL] [Abstract][Full Text] [Related]
2. Influence of classic and atypical neuroleptics on caffeine oxidation in rat liver microsomes.
Daniel WA; Kot M; Wójcikowski J
Pol J Pharmacol; 2003; 55(6):1055-61. PubMed ID: 14730101
[TBL] [Abstract][Full Text] [Related]
3. Effects of antidepressant drugs on the activity of cytochrome P-450 measured by caffeine oxidation in rat liver microsomes.
Danie WA; Syrek M; Ryłko Z; Wójcikowski J
Pol J Pharmacol; 2001; 53(4):351-7. PubMed ID: 11990081
[TBL] [Abstract][Full Text] [Related]
4. Effects of classic and newer antidepressants on the oxidation pathways of caffeine in rat liver. In vitro study.
Daniel WA; Kot M; Wójcikowski J
Pol J Pharmacol; 2003; 55(6):1045-53. PubMed ID: 14730100
[TBL] [Abstract][Full Text] [Related]
5. Effects of phenothiazine neuroleptics on the rate of caffeine demethylation and hydroxylation in the rat liver.
Daniel WA; Syrek M; Ryłko Z; Kot M
Pol J Pharmacol; 2001; 53(6):615-21. PubMed ID: 11985335
[TBL] [Abstract][Full Text] [Related]
6. The relative contribution of human cytochrome P450 isoforms to the four caffeine oxidation pathways: an in vitro comparative study with cDNA-expressed P450s including CYP2C isoforms.
Kot M; Daniel WA
Biochem Pharmacol; 2008 Aug; 76(4):543-51. PubMed ID: 18619574
[TBL] [Abstract][Full Text] [Related]
7. Caffeine as a marker substrate for testing cytochrome P450 activity in human and rat.
Kot M; Daniel WA
Pharmacol Rep; 2008; 60(6):789-97. PubMed ID: 19211970
[TBL] [Abstract][Full Text] [Related]
8. Effect of cytochrome P450 (CYP) inducers on caffeine metabolism in the rat.
Kot M; Daniel WA
Pharmacol Rep; 2007; 59(3):296-305. PubMed ID: 17652830
[TBL] [Abstract][Full Text] [Related]
9. Monkey liver cytochrome P450 2C9 is involved in caffeine 7-N-demethylation to form theophylline.
Utoh M; Murayama N; Uno Y; Onose Y; Hosaka S; Fujino H; Shimizu M; Iwasaki K; Yamazaki H
Xenobiotica; 2013 Dec; 43(12):1037-42. PubMed ID: 23679834
[TBL] [Abstract][Full Text] [Related]
10. Metabolism of dacarbazine by rat liver microsomes contribution of CYP1A enzymes to dacarbazine N-demethylation.
Yamagata S; Ohmori S; Suzuki N; Yoshino M; Hino M; Ishii I; Kitada M
Drug Metab Dispos; 1998 Apr; 26(4):379-82. PubMed ID: 9531528
[TBL] [Abstract][Full Text] [Related]
11. In vitro metabolism of pyrethroid pesticides by rat and human hepatic microsomes and cytochrome p450 isoforms.
Scollon EJ; Starr JM; Godin SJ; DeVito MJ; Hughes MF
Drug Metab Dispos; 2009 Jan; 37(1):221-8. PubMed ID: 18948380
[TBL] [Abstract][Full Text] [Related]
12. Catalyzation of cocaine N-demethylation by cytochromes P4502B, P4503A, and P4502D in fish liver.
Arinç E; Bozcaarmutlu A
J Biochem Mol Toxicol; 2003; 17(3):169-76. PubMed ID: 12815613
[TBL] [Abstract][Full Text] [Related]
13. Metabolism of lidocaine by liver microsomes from streptozotocin-diabetic rats.
Gawrońska-Szklarz B; Musial D; Droździk M; Paprota B
Pol J Pharmacol; 2003; 55(2):251-4. PubMed ID: 12926555
[TBL] [Abstract][Full Text] [Related]
14. Identification of rat and human cytochrome p450 isoforms and a rat serum esterase that metabolize the pyrethroid insecticides deltamethrin and esfenvalerate.
Godin SJ; Crow JA; Scollon EJ; Hughes MF; DeVito MJ; Ross MK
Drug Metab Dispos; 2007 Sep; 35(9):1664-71. PubMed ID: 17576809
[TBL] [Abstract][Full Text] [Related]
15. Biotransformation of 6-methoxy-3-(3',4',5'-trimethoxy-benzoyl)-1H-indole (BPR0L075), a novel antimicrotubule agent, by mouse, rat, dog, and human liver microsomes.
Yao HT; Wu YS; Chang YW; Hsieh HP; Chen WC; Lan SJ; Chen CT; Chao YS; Chang L; Sun HY; Yeh TK
Drug Metab Dispos; 2007 Jul; 35(7):1042-9. PubMed ID: 17403915
[TBL] [Abstract][Full Text] [Related]
16. Identification of human cytochrome p450 isozymes involved in diphenhydramine N-demethylation.
Akutsu T; Kobayashi K; Sakurada K; Ikegaya H; Furihata T; Chiba K
Drug Metab Dispos; 2007 Jan; 35(1):72-8. PubMed ID: 17020955
[TBL] [Abstract][Full Text] [Related]
17. Quinolone inhibition of cytochrome P-450-dependent caffeine metabolism in human liver microsomes.
Fuhr U; Wolff T; Harder S; Schymanski P; Staib AH
Drug Metab Dispos; 1990; 18(6):1005-10. PubMed ID: 1981505
[TBL] [Abstract][Full Text] [Related]
18. Effects of selective cytochrome P-450 inhibitors on the metabolism of thioridazine. In vitro studies.
Daniel WA; Syrek M; Haduch A
Pol J Pharmacol; 1999; 51(5):435-42. PubMed ID: 10817545
[TBL] [Abstract][Full Text] [Related]
19. Decreased in vivo metabolism of drugs in chronic renal failure.
Leblond FA; Giroux L; Villeneuve JP; Pichette V
Drug Metab Dispos; 2000 Nov; 28(11):1317-20. PubMed ID: 11038159
[TBL] [Abstract][Full Text] [Related]
20. Decreases in phenytoin hydroxylation activities catalyzed by liver microsomal cytochrome P450 enzymes in phenytoin-treated rats.
Yamazaki H; Komatsu T; Takemoto K; Saeki M; Minami Y; Kawaguchi Y; Shimada N; Nakajima M; Yokoi T
Drug Metab Dispos; 2001 Apr; 29(4 Pt 1):427-34. PubMed ID: 11259327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
